Experts tell committee H.583 would curb private‑equity control of Vermont physician practices

MONTPELIER—Experts advising a legislative committee on Jan. 30 said H.583, the corporate‑practice‑of‑medicine bill under consideration, would strengthen state oversight of investor control over physician practices and improve public visibility into who owns and controls health‑care providers.

Michael Fenney, senior policy coordinator at the Private Equity Stakeholder Project, told committee members that states are exposed to financial and access risks when private equity owners place debt on operating providers, use sale‑leaseback transactions or take dividends that leave provider organizations financially constrained. "When capital exits or fails, states are left managing access disruption, fiscal exposure and regulatory response," Fenney said, describing those downstream risks and saying existing state tools often respond to harms after they appear rather than preventing risky financial tactics.

Why it matters: Witnesses tied those financial strategies to measurable harms. Fenney pointed to the Steward Health Care case—a multi‑state system that entered Chapter 11 after large sale‑leaseback and dividend transactions—as an example of debt structures shifting risk onto operating entities. The panelists said earlier visibility into ownership, debt and control relationships would help regulators intervene before service cuts or closures.

Health‑economics evidence: Yasaswini Singh, an assistant professor of health services policy and practice at Brown University, described peer‑reviewed studies finding that private‑equity acquisitions in specialty physician practices increased negotiated prices (about 11%) and list prices (about 20%) and raised utilization of ancillary services. She said one study of ophthalmology clinics documented roughly a 20% decline in retinal‑detachment surgery after buyouts, a change that can have serious consequences for patient outcomes.

Singh also discussed workforce effects: "Following PE buyouts, physician turnover increases from about 5% of baseline to over 20%," she said, describing evidence of higher clinician replacement ratios and greater reliance on advanced practice providers.

Vermont context and addiction treatment: On Vermont specifics, Singh said researchers have not identified any PE‑owned hospitals in the state as of their most recent data, but noted that about one quarter of Vermont nursing homes are PE‑backed and that roughly 57% of Vermont opioid treatment programs (OTPs; methadone clinics) were PE‑affiliated. "OTPs are the only settings where methadone can be dispensed now," she said, adding that higher reimbursement and staffing changes can create incentives that do not always expand access to methadone.

Legal and policy tools: Erin Foussey Brown, a lawyer at the Brown University School of Public Health, focused on how management services organizations (MSOs) operate and how statute can address them. Brown explained the "friendly physician" model—where a physician on paper owns or leads a practice while investor‑controlled MSOs manage revenue, hiring, payer contracting and clinical‑adjacent decisions—and described statutory options: codifying corporate‑practice‑of‑medicine prohibitions, banning restrictive employment covenants (noncompete, nondisclosure, nondisparagement), and instituting ownership‑transparency reporting or registries. She said the NASHP model and some states require reporting of ultimate owners and material changes in control, with variations in enforcement mechanisms.

State comparisons: Panelists contrasted recent state action. Fenney and Brown described Massachusetts’s H.5159 as notable for requiring ownership registration and restricting some sale‑leaseback‑style arrangements, Pennsylvania’s draft bill (cited as a pre‑transaction review model) as more aggressive on pre‑approval, and California and Oregon as taking differing approaches to corporate practice rules and PE‑specific restrictions. Brown said Oregon’s oversight plus statutory CPOM language is among the stronger models but includes carveouts; she said Vermont’s draft bill would make the state among the more assertive in the nation if enacted as written.

Committee concerns and balancing investment: Committee members asked whether H.583 would block useful capital or affiliations. Witnesses replied that the bill’s design can preserve lawful and beneficial investments—billing, IT or other MSO services—while banning the specific kinds of control that undermine clinicians’ authority over clinical decisions. "You can still hire a service provider to do billing and collections; the practice should retain ultimate decisionmaking authority," Brown said.

What happens next: The hearing concluded with committee questions and no recorded vote in the transcript. Committee members signaled ongoing review of H.583’s text, enforcement options and the practical balance between access to capital and clinical safeguards.

Quotes in context: All direct quotations and factual claims in this report come from witnesses who spoke at the Jan. 30 committee session: Michael Fenney (Private Equity Stakeholder Project), Yasaswini Singh (Brown University), and Erin Foussey Brown (Brown University School of Public Health). The committee session included back‑and‑forth questioning from committee members, including a questioner identified as Brian and the moderator.